Health Care & Life Sciences » Pharmaceuticals | Changchun High & New Technology Industries

Changchun High & New Technology Industries | Mutual Funds

Mutual Funds that own Changchun High & New Technology Industries

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
1,700,571
1%
539,338
2.86%
12/31/2017
China Universal Stable Growth Fund
1,308,365
0.77%
1,308,365
6.46%
12/31/2017
1,207,399
0.71%
-151,693
13.14%
12/31/2017
Bosera Emerging Growth Equity Fund
1,181,044
0.7%
1,181,044
9.15%
12/31/2017
GF Stable Growth Fund
900,000
0.53%
100,000
6.35%
12/31/2017
Industrial Global Vision Equity Fund
855,088
0.5%
855,088
13.94%
12/31/2017
848,596
0.5%
848,596
9.85%
12/31/2017
LC New Trend Equity Fund
829,872
0.49%
0
7.06%
12/31/2017
LC New Blue Chip Balanced Fund
779,708
0.46%
0
4.55%
12/31/2017
744,128
0.44%
552,650
6.79%
12/31/2017

About Changchun High & New Technology Industries

View Profile
Address
5/F, Huoju Building
Changchun Jilin 130021
China
Employees -
Website http://www.cchn.com.cn
Updated 07/08/2019
Changchun High & New Technology Industries (Group), Inc. engages in the research and development, production, and sale of biopharmaceuticals and proprietary Chinese medicines. It involves in real estate development and leasing, and property management. The company was founded in June 1993 and is headquartered in Changchun, China.